Wealth Enhancement Trust Services’s TuHURA Biosciences HURA Stock Holding History

Wealth Enhancement Trust Services’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$2	﹤0.01%	1527

Other funds holding HURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WealthShield Partners Cary, North Carolina $654M AUM 26.48% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

CFM

Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Wealth Enhancement Trust Services's HURA Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #1527 among its holdings.

50 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Wealth Enhancement Trust Services held 1 share of TuHURA Biosciences worth $2 as of Q2 2026.
TuHURA Biosciences was a new Wealth Enhancement Trust Services position in Q2 2026.
TuHURA Biosciences made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1527 holding.
50 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.